Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study
By
Ezekiel Musa
Esteban Salazar-Petres
Glory Chinuru Musa
Fatima Bello
Adamu Girei Bakari
June 16, 2026
Clinical Scorecard: Association of Serum Testosterone Levels with Cardiometabolic Risk in Nigerian Males Diagnosed with Type 2 Diabetes: A Cross-Sectional Analysis
At a Glance
Category Detail
Condition Key Mechanisms Testosterone deficiency may worsen atherosclerotic cardiovascular disease (ASCVD) risk. [Source needed] Target Population Care Setting
Key Highlights
Serum testosterone is not independently associated with ASCVD risk after multivariable adjustment. [Source needed] Guideline-Based Recommendations
Diagnosis
Management
Monitor cardiometabolic risk factors in T2DM men, particularly those with low testosterone. [Source needed] Monitoring & Follow-up
Risks
Patient & Prescribing Data
Testosterone deficiency is prevalent but does not independently predict ASCVD risk. [Source needed]
Clinical Best Practices
Consider the impact of obesity on testosterone levels in diabetic men. [Source needed] Related Resources & Content
